Halozyme Therapeutics, Inc.

HALONASDAQHealthcare● Active

$71.37

$-0.16(-0.22%)

Market Cap$8.5B

P/E Ratio—

52W High$82.22

52W Low$51.06

Avg Volume1.6M

Open$71.59

Beta0.87

Employees Ownership Insider Trades

Halozyme Therapeutics, Inc. (HALO) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · HALO · as of Feb 17, 2026

Latest filing snapshot

423

+73+20.86%vs prior year

Halozyme Therapeutics, Inc. (HALO) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 10-K·Period end: 2025-12-31·Full-time · Global

Total Employees

423

Change (1Y)

+73

Growth % (1Y)

+20.86%

Revenue / Employee

$3.30M

Net Income / Employee

$749.1K

Market Cap

$8.5B

HALO Employee Count

2006 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing Date	Period End	Employees	Change (1Y)	Growth (1Y)
2026-02-17	2025-12-31	423	+73	+20.86%
2025-02-18	2024-12-31	350	-23	-6.17%
2024-02-20	2023-12-31	373	-20	-5.09%
2023-02-21	2022-12-31	393	+248	+171.03%
2022-02-22	2021-12-31	145	+9	+6.62%
2021-02-23	2020-12-31	136	+4	+3.03%
2020-02-24	2019-12-31	132	-149	-53.02%
2019-02-21	2018-12-31	281	+26	+10.20%
2018-02-20	2017-12-31	255	-4	-1.54%
2017-02-28	2016-12-31	259	+43	+19.91%

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology

#SymbolCompanyEmployeesMkt Cap

CAI

Caris Life Sciences, Inc.

1,769$4.7B

CORT

Corcept Therapeutics Incorporated

500$8.0B #5

CYTK

Cytokinetics, Incorporated

498$8.6B #6

HALO

Halozyme Therapeutics, Inc.YOU

Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · HALO peer comparison

About HALO employees

HALO Employees · Headcount

Halozyme Therapeutics, Inc. (HALO) employee data is sourced from the annual SEC 10-K filing. As of 2025, Halozyme Therapeutics, Inc. had 423 full-time employees globally. Full-time employees only. Global consolidated headcount.

Halozyme Therapeutics, Inc. employs 423 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $3.30M, reflecting the company's operational efficiency.

Halozyme Therapeutics, Inc.'s workforce increased by 73 (20.86%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Halozyme Therapeutics, Inc.'s revenue per employee of $3.30M positions it among the notable performers in the Biotechnology sector for operational efficiency.

Revenue Financial statements Net income SEC filings Price history Forecast & ratings Ownership Earnings

Frequently Asked Questions

HALO Employees · 5 questions

As of the latest SEC 10-K filing (2025), Halozyme Therapeutics, Inc. had 423 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Halozyme Therapeutics, Inc. employee counthow many employees does Halozyme Therapeutics, Inc. haveHALO total employees 2025

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-02-17